drugset / Trial / NCT00277810
Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to determine the safety, tolerability, and efficacy of 3 doses of lecozotan in combination with a cholinesterase inhibitor in patients with mild to moderate Alzheimer's disease (AD).
Timeline
- Start
- 2006-03
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lecozotan | Small molecule | 2 mg | — |
| Subject | Lecozotan | Small molecule | 5 mg | — |
| Subject | Lecozotan | Small molecule | 10 mg | — |